SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Clinigence Holdings, Inc. CLNH OTC

Other OTC • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Clinigence Holdings, Inc. (CLNH) is a Medical - Healthcare Information Services company in the Healthcare sector, currently trading at $6.40. It has a SharesGrow Score of 77/100, indicating a strong investment profile with 4 out of 7 criteria passed.

Financials: revenue is $875M, +851290018.2%/yr average growth. Net income is $180M, growing at +127235183.2%/yr. Net profit margin is 20.6% (strong). Gross margin is 50.8% (+8.2 pp trend).

Balance sheet: total debt is $321M against $423M equity (Debt-to-Equity (D/E) ratio 0.76, moderate). Current ratio is 3.41 (strong liquidity). Debt-to-assets is 35%. Total assets: $919M.

SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 100/100 (Pass), Past 50/100 (Partial), Health 83/100 (Pass), Moat 58/100 (Partial), Future ?/100 (Fail), Income 85/100 (Pass).

CLNH SharesGrow Score Overview

79/100

SharesGrow Score

Strong investment profile

View full scorecard →

VALUE 100/100

Valuation — P/E, PEG, Forward PEG

GROWTH 100/100

Financials — average growth

PAST 50/100

strong — trend

HEALTH 83/100

Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is

MOAT 58/100

Gross margin is + market cap

FUTURE 0/100

Analyst outlook — as buy

INCOME 85/100

Net profit margin is

Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — CLNH

CLNH trades at a trailing Price-to-Earnings (P/E) of N/A (S&P 500 average ~25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

CLNH: +851290018.2%/yr revenue is, +127235183.2%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

CLNH: 2 / 4 years profitable. weak. Score = 2 / 4 × 100. ≥ 80 = Pass.

View details →

Balance sheet CLNH: Debt-to-Equity (D/E) ratio 0.76 (moderate), Current ratio is 3.41 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

CLNH: Gross margin is 50.8% (+8.2 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 58/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

CLNH: Net profit margin is 20.6%. healthy (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

Market Data

52-Week Range6.4-6.4

Volume128.79K

Avg Volume (30D)7.08K

Beta (1Y)0.00

Share Statistics

EPS (TTM)36.49

Shares Outstanding$4.94M

IPO Date2021-01-08

Employees12

CEOWarren Hosseinion

Financial Highlights & Ratios

Revenue (TTM)$875.26M

Gross Profit$444.28M

EBITDA$287.54M

Net Income$180.36M

Operating Income$275.63M

Total Cash$185.57M

Total Debt$321.48M

Net Debt$135.91M

Total Assets$918.53M

Price / Earnings (P/E)0.2

Analyst Forecast

Company Info

CountryUS

ExchangeOther OTC

CurrencyUSD

ISINUS18727D1054

Price Chart

CLNH

Clinigence Holdings, Inc. ↗ · Other OTC

Healthcare • Medical - Healthcare Information Services

People Also View

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message